Tvardi Therapeutics(CH:TVRD)
CH:TVRD
Tvardi Therapeutics similar stocks
Compare Tvardi Therapeutics (TVRD) vs. Competitors
2 Followers
Comparison Results
| Name | Price | Market Cap | P/E Ratio | Yearly Gain | Analyst Consensus | Analyst Price Target | Compare | Top Analysts' Price Target | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
| CH:TVRDTvardi Therapeutics | CHF 12.92M | -0.42 | ― | Moderate Buy | Unlock the CH:TVRD analyst price target with TipRanks Premium | CH:TVRD | Unlock the CH:TVRD top-analyst price target with TipRanks Premium | |||
| CUECue Biopharma | $16.12 | $127.13M | -0.60 | -13.28% | Moderate Buy | Unlock the CUE analyst price target with TipRanks Premium | CH:TVRD vs CUE | Unlock the CUE top-analyst price target with TipRanks Premium | ||
| ALGSAligos Therapeutics | $2.10 | $13.96M | -0.33 | -65.40% | Moderate Buy | Unlock the ALGS analyst price target with TipRanks Premium | CH:TVRD vs ALGS | Unlock the ALGS top-analyst price target with TipRanks Premium | ||
| ANLAdlai Nortye Ltd. Sponsored ADR | $10.61 | $677.47M | -5.42 | 602.65% | Strong Buy | Unlock the ANL analyst price target with TipRanks Premium | CH:TVRD vs ANL | Unlock the ANL top-analyst price target with TipRanks Premium |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| CH:TVRD | Tvardi Therapeutics | ― | ― | ― | |
| CUE | Cue Biopharma | 16.12 | -1.10 | -6.39% | |
| ALGS | Aligos Therapeutics | 2.10 | -4.92 | -70.09% | |
| ANL | Adlai Nortye Ltd. Sponsored ADR | 10.61 | 9.04 | 575.80% |
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
